Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Enzyme-Linked Immunosorbent Assay01:33

Enzyme-Linked Immunosorbent Assay

13.9K
In 1971, Peter Perlman and Eva Engvall developed an Enzyme-linked immunosorbent assay (ELISA or EIA). ELISA differs from western blot in that the assays are conducted in microtiter plates or in vivo rather than on an absorbent membrane.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen.  Enzyme-substrate reaction allows the antigen to be visualized or...
13.9K
Immunofluorescence Microscopy01:12

Immunofluorescence Microscopy

10.8K
A fluorescence microscope uses fluorescent chromophores called fluorochromes, which can absorb energy from a light source and then emit this energy as visible light. Fluorochromes include naturally fluorescent substances (such as chlorophylls) and fluorescent stains that are added to the specimen to create contrast. Dyes such as Texas red and FITC are examples of fluorochromes. Other examples include the nucleic acid dyes 4’,6’-diamidino-2-phenylindole (DAPI), and acridine orange.
10.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

History of antineutrophil cytoplasmic autoantibodies : Milestones in rheumatology.

Zeitschrift fur Rheumatologieยท2024
Same author

[Laboratory diagnostics for vasculitis beyond antineutrophil cytoplasmatic autoantibodies].

Zeitschrift fur Rheumatologieยท2024
Same author

Spectrum of ANCA-specificities in eosinophilic granulomatosis with polyangiitis. A retrospective multicentre study.

Clinical and experimental rheumatologyยท2023
Same author

Evaluation of PR3- and MPO-ANCA line and dot immunoassays in ANCA-associated vasculitis.

Rheumatology (Oxford, England)ยท2020
Same author

Autoantibody profile in eosinophilic granulomatosis and polyangiitis: predominance of anti-alpha-enolase antibodies.

Clinical and experimental rheumatologyยท2020
Same author

Harmonization of antineutrophil cytoplasmic antibodies (ANCA) testing by reporting test result-specific likelihood ratios: position paper.

Clinical chemistry and laboratory medicineยท2020

Related Experiment Video

Updated: Aug 8, 2025

Simultaneous Distinction of Monospecific and Mixed DFS70 Patterns During ANA Screening with a Novel HEp-2 ELITE/DFS70 Knockout Substrate
10:05

Simultaneous Distinction of Monospecific and Mixed DFS70 Patterns During ANA Screening with a Novel HEp-2 ELITE/DFS70 Knockout Substrate

Published on: January 17, 2018

36.1K

[Methods of autoantibody diagnostics - when immunofluorescence test, when ELISA?]

Elena Csernok

    Deutsche Medizinische Wochenschrift (1946)
    |February 27, 2023
    PubMed
    Summary

    Detecting autoantibodies is crucial for diagnosing autoimmune diseases, often years before symptoms appear. This review covers immunoassay methods for identifying these critical biomarkers.

    Area of Science:

    • Clinical Immunology
    • Autoimmunity Research
    • Diagnostic Biomarkers

    Background:

    • Autoantibodies are key to diagnosing systemic and organ-specific autoimmune diseases.
    • Autoantibody detection aids in classification, diagnosis, and prediction of disease onset.
    • Early detection of autoantibodies can precede clinical manifestation by years.

    Approach:

    • This review examines the evolution of laboratory methods for autoantibody detection.
    • It contrasts conventional (monoplex) assays with advanced multiplex platforms.
    • Various diagnostic immunoassays currently used in clinical practice are presented.

    Key Points:

    • Immunoassays are vital for identifying autoantibodies against cellular molecules.
    • The development of autoantibody detection methods marks significant progress in clinical immunology.

    More Related Videos

    Generation of Two-color Antigen Microarrays for the Simultaneous Detection of IgG and IgM Autoantibodies
    10:16

    Generation of Two-color Antigen Microarrays for the Simultaneous Detection of IgG and IgM Autoantibodies

    Published on: September 15, 2016

    12.9K
    Electrochemiluminescence Assays for Human Islet Autoantibodies
    09:15

    Electrochemiluminescence Assays for Human Islet Autoantibodies

    Published on: March 23, 2018

    15.5K

    Related Experiment Videos

    Last Updated: Aug 8, 2025

    Simultaneous Distinction of Monospecific and Mixed DFS70 Patterns During ANA Screening with a Novel HEp-2 ELITE/DFS70 Knockout Substrate
    10:05

    Simultaneous Distinction of Monospecific and Mixed DFS70 Patterns During ANA Screening with a Novel HEp-2 ELITE/DFS70 Knockout Substrate

    Published on: January 17, 2018

    36.1K
    Generation of Two-color Antigen Microarrays for the Simultaneous Detection of IgG and IgM Autoantibodies
    10:16

    Generation of Two-color Antigen Microarrays for the Simultaneous Detection of IgG and IgM Autoantibodies

    Published on: September 15, 2016

    12.9K
    Electrochemiluminescence Assays for Human Islet Autoantibodies
    09:15

    Electrochemiluminescence Assays for Human Islet Autoantibodies

    Published on: March 23, 2018

    15.5K
  • Multiplex platforms enable simultaneous quantification of numerous autoantibodies.
  • Conclusions:

    • Accurate autoantibody detection is fundamental for autoimmune disease diagnosis and management.
    • Advancements in immunoassay technology have significantly improved diagnostic capabilities.
    • Understanding autoantibody profiles aids in early disease prediction and personalized medicine.